Emerj AI Research

Does your leadership team have the range to move across biology, chemistry, and informatics with enough credibility to break down silos? Barry Bunin of CDD Vault on the competency most R&D orgs aren't developing. Before your next AI sprint — listen here: zurl.co/ql5NQ

How can HR teams move from manual processes to machine-scale talent operations? Sachit Kamat of @eightfoldai breaks it down on the @Emerj #AIinBusiness podcast — from automated interviews to compliance-ready workflows: zurl.co/cJIyC

What does AI productivity actually look like when it reaches the people doing the work? @emerj sits down with Lawrence Whittle of HTEC Group. Worth your 45 minutes: zurl.co/GClu7 #AIinBusiness

Context defines reliable AI decisions. Ravi Marwaha, CPTO @arangoai, examines how fragmentation blocks AI on the @Emerj #AIinBusiness @arangoai‑sponsored podcast, and the steps leaders can take to unify it: zurl.co/GPVfz

Manufacturing knowledge walks out the door. @Emerj sits down with Anand Gnanamoorthy, Director of Corporate Strategy and AI at @IngersollRand, on the #AIinBusiness podcast. Sponsored by @PokaInc zurl.co/e9fCf

The easy-button AI use case isn't the one that moves the needle. @Emerj sits down with Niken Patel, CEO of @Neuron7, on the #AIinBusiness podcast. zurl.co/2fZqK

The AI platform debate is downstream of a more important decision. Barry Bunin, CEO at CDD Vault, on why cross-functional data generation is what separates drug discovery leaders from laggards. @emerj #AIinHealth — See what changes first: zurl.co/5rqzN

Patricio Rivera, Former VP of HSE International at Oxy, explains how operational drift becomes visible early in asset‑intensive industries. His framework shows leaders how to protect continuity before costs escalate. Listen via @Emerj #AIinBusiness for the full breakdown: zurl.co/1WiO8

AI is changing insurance economics by improving the decisions that never stop repeating — claims and exposure. @Emerj breaks down two Travelers use cases that show where real leverage is emerging and what leading carriers are prioritizing next: zurl.co/gpCWe

Pilot failure is dampening AI investment confidence, and leaders want deployments that deliver real, repeatable value. Lawrence Whittle of @HTECgroup breaks down why smaller real builds, tight cost‑to‑value ratios, and culture drive momentum. @Emerj #AIinBusiness podcast: zurl.co/TwXl6

@aboutKP is leveraging AI to enhance communication, manage risks, and improve patient experiences. Key use cases include healthcare perception mapping and compliance risk evaluation. #AIinHealthcare zurl.co/m8gWH

The data to stop burnout is already there. @Emerj sits down with Tony Pastorino, Director of Healthcare Strategy at @Resultant, on the #AIinHealthcareandLifeSciences podcast. zurl.co/nWteN

AI adoption can fail before a model is trained. The issue is not always the algorithm. It is the business decision that comes first. Our guide helps non-technical leaders assess AI value, data readiness, and ROI risk before investment. zurl.co/a96VR

Fraud scripts go viral in criminal networks in hours. A monolithic model can't tell you what stopped working. Ken Morino of Modulate on @emerj #AIinBusiness. Full breakdown: zurl.co/oigYX

Stabilizing the operational environment around underwriting judgment is becoming the real lever for speed. On the #AIinFinancialServices podcast, @Emerj speaks with Barbara Stacer, VP, Head of Small Commercial Underwriting & Underwriting Operations, on how governed workflows move pricing into the market with consistency and control: zurl.co/rhtCU

Cost unpredictability erodes planning, pricing, and margin when AI shifts work from human‑paced to system‑paced execution. Alex Tyrrel, CTO Health @Wolters_Kluwer breaks down how autonomy reshapes cost, governance, and visibility on the @Emerj #AIinBusiness podcast. zurl.co/4FlHq

Voice has been business's trust layer for centuries. What happens when AI quietly dismantles it? Ken Morino of Modulate joins @emerj on #AIinBusiness. Worth your 45 minutes: zurl.co/RSBem

AI systems now act like quasi‑employees. Naveen Kumar of @TDBank_US breaks down why leaders must separate retail growth risk from compliance risk and enforce guardrails that can’t be bypassed. Full article at @Emerj: zurl.co/hu1qP

.@Merck invests over $1.2B in #AI to transform #pharma. Our analysis of key use cases show how these investments accelerate drug manufacturing and streamline regulatory #compliance, reducing costs and delays: zurl.co/3YXxK

Do your programme leads understand what GenAI is actually computing — or just what it's producing? Juan Orlandini with @emerj on the distinction that determines renewal. Sponsored by K1x. See what changes first: zurl.co/H6wm1